DCGO - DocGo Inc.
Lumexa Imaging (NASDAQ: LMRI - Get Free Report) and DocGo (NASDAQ: DCGO - Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, valuation, dividends, institutional ownership, profitability and risk. Institutional and Insider Ownership 56.4% of DocGo shares
DocGo (NASDAQ: DCGO) outlined its planned acquisition of virtual acute-care provider Hicuity Health, describing the transaction as a step toward building a connected care platform spanning hospital-based services, medical transportation, in-home care and remote monitoring. Chief Executive Officer Lee Bienstock said the combination is intended to help health systems manage increasing patient demand, clinician shortages and
DocGo Inc. (DCGO) Discusses Pending Acquisition of Hicuity Health and Related Financial Projections Transcript
Shares of DocGo Inc. (NASDAQ: DCGO - Get Free Report) have received a consensus recommendation of "Hold" from the six brokerages that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell rating, two have assigned a hold rating and three have assigned a buy rating to the company. The
DocGo Inc. (Nasdaq: DCGO) (âDocGoâ), a leading provider of technology-enabled mobile health and medical transportation services, announced today that Lee Bi
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health and medical transportation services, announced today that Lee Bienstock, Chief Executive Officer, and senior Hicuity Health executives will conduct a webinar on Tuesday September 29th at 11:00 a.m. ET to discuss DocGo's pending acquisition of Hicuity Health – a leading provider of tele-ICU, virtual nursing, telemetry monitoring and additional virtual care services to hospitals.
DocGo Inc. (DCGO) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
DocGo Inc. (Nasdaq: DCGO) (âDocGoâ), a leading provider of technology-enabled mobile health and medical transportation services, announced today that Lee Bi
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health and medical transportation services, announced today that Lee Bienstock, Chief Executive Officer, will participate in 1x1 meetings at the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday September 16th, and will deliver a fireside presentation at 12:20 PM ET on that day. A webcast of the event will be available on the investor relations section of DocGo's we.
DocGo NASDAQ: DCGO reported second-quarter revenue of $73.4 million, down from $80.4 million a year earlier, as the company continued to wind down migrant-related projects. Excluding migrant-related revenue, revenue rose 19% year over year, while revenue from business lines operating in both periods increased about 5% after also excluding contributions from the SteadyMD acquisition.
DocGo Inc. (DCGO) Q2 2026 Earnings Call Transcript
DocGo Inc. (DCGO) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of a loss of $0.04 per share. This compares to a loss of $0.11 per share a year ago.
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial and operating results for the second quarter ended June 30, 2026. Second Quarter 2026 Financial Highlights Total revenue for the second quarter of 2026 was $73.4 million, compared to $80.4 million in the second quarter of 2025. This decline was entirely due to the wind-down of migrant-related progra.
DocGo Inc. (NASDAQ:DCGO) will release its second earnings report after the closing bell on Monday, Aug. 17.
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, announced today that the Company will release its financial results for the second quarter ended June 30, 2026 after the markets close on Monday, August 17, 2026. Management will also host a conference call to discuss these results at 5:00 p.m. ET on that day. Conference call and webcast details: Monday, August 17, 2026 5:00.
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
DocGo Inc. (DCGO) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
DocGo Inc. (Nasdaq: DCGO) (âDocGoâ or the âCompanyâ), a leading provider of technology-enabled mobile health and medical transportation services, today
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, today announced that its PTI Health by DocGo subsidiary has launched mobile phlebotomy services in Southern Florida. In conjunction with this launch, PTI Health has expanded its relationship with a major national clinical laboratory to cover services throughout the Southeast and will work collaboratively with this lab partne.
DocGo NASDAQ: DCGO Chief Executive Officer Lee Bienstock outlined the company's transition away from COVID-related, migrant and emergency-response programs and toward its “evergreen” medical transportation and mobile health businesses during a presentation at the 21st Annual Needham Technology, Media, and Consumer Conference.